Insulin and insulin analogs: cancer risk assessment As one of the most effective anti-diabetic therapies currently available, insulin therapy for glycemic control carries risks of hypoglycemia and weight gain
The clinical expert highlighted the following outcomes that are important when assessing whether a patient is responding to treatment in clinical practice: improvement in glycemic parameters, improvement in body weight with the attendant improvement in blood pressure and lipids, and long-range improvement in microvascular and macrovascular events, in addition to improvement in quality of life
Primary glutathione synthesis defects are rare but real
It could also cause adverse effects
Scientific References: Le Roith D, Bondy C, Yakar S, Liu JL, Butler A., Endocrine Reviews , 2001